Karman Holdings enters the final stretch before its August 7 earnings report with short interest now at a fresh multi-month peak and the stock attempting a partial recovery — a combination that sharpens the stakes on the upcoming print considerably.
Short sellers have continued to press their case since last week's note. Short interest has climbed further to 10.7% of the free float, up 14% in the past week and now 73% higher than a month ago. The seven-day pace of accumulation has not slowed: shorts added another 600,000 shares this week on top of the 3.4 million added in the prior session. The picture that emerges is a methodical, sustained rebuild rather than a panic-driven spike. What remains unchanged, however, is the lending market's posture. Availability has tightened sharply — down 59% on the week to 187% — still comfortably in the normal range, but the directional move is worth watching. Cost to borrow has edged up 20% over the week to just 0.53%, still low enough to pose no meaningful friction for new shorts. The borrow market is not yet stressed, but availability is compressing at a pace that, if continued, will begin to change the economics of adding to the short position. The ORTEX short score has risen to 65.2, its highest level in the observable window and up sharply from 53.5 two weeks ago — a composite signal that the short setup has intensified across multiple dimensions.
Options positioning offers a partial counterpoint to the short-side pressure. The put/call ratio has dropped to 1.06, nearly 1.7 standard deviations below its 20-day average of 1.17. That is the most call-leaning options print in weeks — a rotation away from the defensive hedging that dominated the prior fortnight. The stock itself closed at $46.67, up 4% on the day and 1.8% on the week, after a difficult month that has left it down 7.3%. This creates an unusual divergence: shorts methodically rebuilding at multi-month highs, while options traders rotate toward calls and the stock bounces. The two signals are pulling in opposite directions heading into what has historically been a volatile earnings event.
The Street backdrop remains constructive in direction but has become meaningfully less bullish in magnitude. The most recent move from a bellwether firm came from Citigroup on July 1, when analyst John Godyn trimmed his target from $97 to $76 while maintaining a Buy — the second successive cut from that desk since May. The mean analyst target still runs around $103, roughly double the current stock price; however, given the consistent target-lowering trend across multiple firms since May, that gap reflects more about where analysts thought the stock would be six months ago than current conviction. Piper Sandler, Keybanc, and Evercore all cut targets in May without changing their positive ratings, and one lone Sell-rated name from BWS Financial has maintained a $37 target throughout. The factor scores add nuance: the short-score rank is in the 7th percentile, meaning shorts are positioned more aggressively here than in 93% of comparable names. EPS momentum over 30 days is strong at the 81st percentile, but forward-year EPS growth ranks in just the 8th percentile — a split that suggests near-term beats but structural growth questions. On valuation, the stock trades at 27x EV/EBITDA and 60x trailing PE, multiples that have compressed modestly over the past month as the stock has pulled back, but that still price in a meaningful recovery narrative.
Institutional flows provide some grounding context. FMR added over 2.5 million shares as of May, bringing its stake to 6.3% of shares outstanding. BlackRock added 500,000 shares through June 30. First Trust added nearly 1.9 million shares in the same period. Against that backdrop, the executive-level selling that took place in late 2025 — the CEO sold 300,000 shares across four weekly tranches at prices between $58 and $69, while the CFO and COO also sold into strength — leaves the insider picture as a net drain at levels well above where the stock now trades. That data is now stale at seven months old, but the directional read remains relevant: insiders were using strength to reduce exposure.
The prior earnings event on May 12 produced a 14% single-day gain and a 9% five-day follow-through — the market's strongest reaction to a KRMN print on record. The question heading into August 7 is whether the short buildup of the past three weeks reflects genuine concern about a reversal of that outcome, or simply tactical positioning that gets unwound if the company delivers another beat. The rate at which lending availability continues to compress between now and earnings day is the clearest near-term signal worth tracking.
See the live data behind this article on ORTEX.
Open KRMN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
